AIP
LRMR icon

Ameritas Investment Partners’s Larimar Therapeutics LRMR Stock Holding History

Ameritas Investment Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5K Hold
4,121
– – ﹤0.01% 2625
2025
Q4 		$15.7K Hold
4,121
– – ﹤0.01% 2752
2025
Q3 		$13.3K Hold
4,121
– – ﹤0.01% 2856
2025
Q2 		$11.9K Hold
4,121
– – ﹤0.01% 2917
2025
Q1 		$8.86K Hold
4,121
– – ﹤0.01% 2862
2024
Q4 		$15.9K Hold
4,121
– – ﹤0.01% 2726
2024
Q3 		$27K Hold
4,121
– – ﹤0.01% 2504
2024
Q2 		$29.9K Buy
4,121
+2,003
+95% +$15.3K ﹤0.01% 2429
2024
Q1 		$16.1K Hold
2,118
– – ﹤0.01% 2651
2023
Q4 		$9.64K Hold
2,118
– – ﹤0.01% 2850
2023
Q3 		$8.37K Hold
2,118
– – ﹤0.01% 2886
2023
Q2 		$6.63K Buy
+2,118
New +$8.64K ﹤0.01% 2995
2019
Q2 		– Sell
-167
Closed -$5K – 3088
2019
Q1 		$5K Hold
167
– – ﹤0.01% 2859
2018
Q4 		$10K Hold
167
– – ﹤0.01% 2664
2018
Q3 		$23K Hold
167
– – ﹤0.01% 2440
2018
Q2 		$21K Buy
+167
New +$14.2K ﹤0.01% 2486
2017
Q2 		– Sell
-106
Closed -$6K – 3024
2017
Q1 		$6K Buy
+106
New +$5.26K ﹤0.01% 2812

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Ameritas Investment Partners's LRMR Position: Q1 2026 in Review

Ameritas Investment Partners held its Larimar Therapeutics (LRMR) position steady in Q1 2026 at 4,121 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

Ameritas Investment Partners first reported a position in LRMR in Q1 2017 and has held it in 17 quarters since. The position peaked at $29.9K in Q2 2024. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Ameritas Investment Partners held 4,121 shares of Larimar Therapeutics worth $18.5K as of Q1 2026.
  • Ameritas Investment Partners left its Larimar Therapeutics share count unchanged in Q1 2026.
  • Larimar Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2625 holding.
  • Ameritas Investment Partners first reported a position in Larimar Therapeutics in Q1 2017 and has held it in 17 quarters since.
  • Ameritas Investment Partners's Larimar Therapeutics position peaked at $29.9K in Q2 2024.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.